Journal of Medical Surgical and Allied Sciences
Peer Reviewed Open Access Journal
ISSN: 3048-541X
Submit Manuscript
Peer Reviewed Open Access Journal
ISSN: 3048-541X
Submit ManuscriptBy guaranteeing that medicinal materials reach the intended spot in the body with maximum efficacy and few side effects, drug delivery systems (DDS) are essential to modern medicine. However, time-consuming and expensive trial-and-error methods are frequently used in traditional drug delivery systems. Predictive modelling, formulation optimisation, and tailored therapy have all been made possible by the development of artificial intelligence (AI), especially machine learning and deep learning, which have drastically changed pharmaceutical research. This study examines how AI-assisted optimisation affects therapeutic results in drug delivery systems. Advanced drug carrier design, pharmacokinetic and pharmacodynamic behaviour prediction, and real-time drug release monitoring are all made possible by AI technologies. Additionally, specialized delivery methods like nanoparticle-based carriers, which increase drug bioavailability and lower toxicity, are made possible by AI-driven models. AI has a lot of promise, but there are still issues with data quality, regulations, and model interpretability. Future medication delivery is anticipated to be revolutionized by the integration of AI with digital health platforms, nanotechnology, and precision medicine. This study highlights important technologies, applications, difficulties, and opportunities while examining the function of AI-assisted optimization in drug delivery systems and assessing its potential to enhance therapeutic outcomes.
Artificial intelligence, drug delivery systems, machine learning, nanomedicine, personalised medicine, therapeutic optimization
Chou, W. C., Canchola, A., Zhang, F., & Lin, Z. (2025). Machine learning and artificial intelligence in nanomedicine. Wiley interdisciplinary reviews: Nanomedicine and nanobiotechnology, 17(4), e70027.
Du, Y., Yang, P., Liu, Y., Deng, C., & Li, X. (2025). Artificial intelligence in chronic disease self-management: current applications and future directions. Frontiers in Public Health, 13, 1689911.
Harrer, S., Shah, P., Antony, B., & Hu, J. (2019). Artificial intelligence for clinical trial design. Trends in pharmacological sciences, 40(8), 577-591.
Kantesaria, R., & Panda, H. S. (2026). A review on AI-based data-driven models for optimization of nanocarriers as drug delivery systems. ACS Biomaterials Science & Engineering, 12(3), 1397-1418.
Kapoor, D. U., Sharma, J. B., Gandhi, S. M., Prajapati, B. G., Thanawuth, K., Limmatvapirat, S., & Sriamornsak, P. (2024). AI-driven design and optimization of nanoparticle-based drug delivery systems. Science, Engineering and Health Studies, 24010003-24010003.
Kaur, J., Kaur, H., Kumar, R., Aidhen, J. S., Kulkarni, K., Mahajan, P., & Pathan, H. M. (2025, September). An AI-integrated approach to nano-based drug delivery systems: Advances in targeting and smart nano-carriers. In 2025 2nd International Conference on Integration of Computational Intelligent System (ICICIS) (pp. 1-7). IEEE.
Mak, K. K., & Pichika, M. R. (2019). Artificial intelligence in drug development: present status and future prospects. Drug discovery today, 24(3), 773-780.
Mamoshina, P., Vieira, A., Lane, E., & Zhavoronkov, A. (2016). Applications of deep learning in biomedicine. Molecular pharmaceutics, 13(5), 1445-1454.
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021). Engineering precision nanoparticles for drug delivery. Nature reviews drug discovery, 20(2), 101-124.
Panchpuri, M., Painuli, R., & Kumar, C. (2025). Artificial intelligence in smart drug delivery systems: A step toward personalized medicine. RSC pharmaceutics, 2(5), 882-914.
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., ... & Shin, H. S. (2018). Nano based drug delivery systems: recent developments and future prospects. Journal of nanobiotechnology, 16(1), 71.
Ros, H., Chan, N., Cook, M. T., & Shorthouse, D. (2026). Artificial intelligence and machine learning guided optimization in drug delivery. Advanced Drug Delivery Reviews, 115781.
Samathoti, P., Kumarachari, R. K., Bukke, S. P. N., Rajasekhar, E. S. K., Jaiswal, A. A., & Eftekhari, Z. (2025). The role of nanomedicine and artificial intelligence in cancer health care: individual applications and emerging integrations - a narrative review. Discover Oncology, 16(1), 697.
Singh, S., & De, A. (2026). The Paradigm Shift in Therapeutics: A Comprehensive Review of Artificial Intelligence in Drug Delivery Systems. RSC Pharmaceutics.
Topol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature medicine, 25(1), 44-56.
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., ... & Zhao, S. (2019). Applications of machine learning in drug discovery and development. Nature reviews Drug discovery, 18(6), 463-477.
Vora, L. K., Gholap, A. D., Jetha, K., Thakur, R. R. S., Solanki, H. K., & Chavda, V. P. (2023). Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics, 15(7), 1916.
Wang, J., Zeng, Z., Li, Z., Liu, G., Zhang, S., Luo, C., ... & Zhao, L. (2025). The clinical application of artificial intelligence in cancer precision treatment. Journal of Translational Medicine, 23(1), 120.
Wu, Y., Ma, L., Li, X., Yang, J., Rao, X., Hu, Y., ... & Liu, S. (2024). The role of artificial intelligence in drug screening, drug design, and clinical trials. Frontiers in Pharmacology, 15, 1459954.
Zhu, T., Liu, B., Chen, N., Liu, Y., Wang, Z., & Tian, X. (2025). Artificial intelligence-driven innovations in pharmaceutical development and drug delivery systems. Current topics in medicinal chemistry, 25(25), 2937-2951.
